You are viewing the site in preview mode
Skip to main content
|
Variable
|
High-risk (No. %)
|
Univariate
| |
Multivariate
| |
|---|
|
No
|
Yes
|
p value
|
OR
|
95% CI
|
p value
|
|---|
|
Age (year)
| | |
0.580
| | | |
|
< 50.5
|
96 (40.5%)
|
50 (21.1%)
| | | | |
|
≥ 50.5
|
63 (26.6%)
|
28 (11.8%)
| | | | |
|
SCCA (ng/ml)
| | |
< 0.001
|
3.282
|
1.675–6.430
|
0.001
|
|
< 2.45
|
95 (41.3%)
|
18 (7.8%)
| | | | |
|
≥ 2.45
|
62 (27.0%)
|
55 (23.9%)
| | | | |
|
FIGO stage
| | |
0.233
| | | |
|
IA2-IB2
|
70 (29.5%)
|
28 (11.8%)
| | | | |
|
IIA1-IIA2
|
89 (37.6%)
|
50 (21.1%)
| | | | |
|
SUVmax
| | |
0.116
| | | |
|
< 7.96
|
36 (15.3%)
|
11 (4.7%)
| | | | |
|
≥ 7.96
|
122 (51.7%)
|
67 (28.4%)
| | | | |
|
MTV
| | |
< 0.001
|
2.749
|
1.230–6.143
|
0.014
|
|
< 20.88
|
66 (28.1%)
|
11 (4.7%)
| | | | |
|
≥ 20.88
|
91 (38.7%)
|
67 (28.5%)
| | | | |
|
TLG
| | |
< 0.001
|
–
|
–
|
0.893
|
|
< 137.40
|
81 (34.5%)
|
20 (8.5%)
| | | | |
|
≥ 137.40
|
76 (32.3%)
|
58 (24.7%)
| | | | |
- Abbreviation: SCCCA Squamous cell carcinoma associated antigen, SUVmax maximum of standardized uptake value, MTV metabolic tumor volume, TLG total lesion glycolysis
